These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15088598)

  • 1. [Inner ear, sense of balance and the skull base]].
    Riemann R
    Laryngorhinootologie; 2004 Mar; 83(3):199. PubMed ID: 15088598
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
    Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
    Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-linked albinism-deafness syndrome and Waardenburg syndrome type II: a hypothesis.
    Zlotogora J
    Am J Med Genet; 1995 Nov; 59(3):386-7. PubMed ID: 8599367
    [No Abstract]   [Full Text] [Related]  

  • 4. Three cases of Waardenburg syndrome type 2 in a Korean family.
    Choi JH; Moon SK; Lee KH; Lew HM; Chang YH
    Korean J Ophthalmol; 2004 Dec; 18(2):185-9. PubMed ID: 15635834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical classification and genetic mutation study of two pedigrees with type II Waardenburg syndrome].
    Chen Y; Yang F; Zheng H; Zhu G; Hu P; Wu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):810-3. PubMed ID: 26663054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible homozygous Waardenburg syndrome in a fetus with exencephaly.
    Aymé S; Philip N
    Am J Med Genet; 1995 Nov; 59(2):263-5. PubMed ID: 8588597
    [No Abstract]   [Full Text] [Related]  

  • 7. A PAX3 polymorphism (T315K) in a family exhibiting Waardenburg Syndrome type 2.
    Wang C; Kim E; Attaie A; Smith TN; Wilcox ER; Lalwani AK
    Mol Cell Probes; 1998 Feb; 12(1):55-7. PubMed ID: 9584079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two different PAX3 gene mutations causing Waardenburg syndrome type I.
    Wildhardt G; Winterpacht A; Hilbert K; Menger H; Zabel B
    Mol Cell Probes; 1996 Jun; 10(3):229-31. PubMed ID: 8799378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of multiple intrachromosomal rearrangements of chromosome 2q in a patient with Waardenburg's syndrome and other congenital defects.
    Shim SH; Wyandt HE; McDonald-McGinn DM; Zackai EZ; Milunsky A
    Clin Genet; 2004 Jul; 66(1):46-52. PubMed ID: 15200507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor hierarchy in Waardenburg syndrome: regulation of MITF expression by SOX10 and PAX3.
    Potterf SB; Furumura M; Dunn KJ; Arnheiter H; Pavan WJ
    Hum Genet; 2000 Jul; 107(1):1-6. PubMed ID: 10982026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Waardenburg syndrome type 3 (Klein-Waardenburg syndrome) segregating with a heterozygous deletion in the paired box domain of PAX3: a simple variant or a true syndrome?
    Tekin M; Bodurtha JN; Nance WE; Pandya A
    Clin Genet; 2001 Oct; 60(4):301-4. PubMed ID: 11683776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cascade of genes related to Waardenburg syndrome.
    Tachibana M
    J Investig Dermatol Symp Proc; 1999 Sep; 4(2):126-9. PubMed ID: 10536986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel mutation in the paired domain of PAX3 in an Iranian family with waardenburg syndrome type I.
    Sotirova VN; Rezaie TM; Khoshsorour MM; Sarfarazi M
    Ophthalmic Genet; 2000 Mar; 21(1):25-8. PubMed ID: 10779847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double heterozygous mutations of MITF and PAX3 result in Waardenburg syndrome with increased penetrance in pigmentary defects.
    Yang T; Li X; Huang Q; Li L; Chai Y; Sun L; Wang X; Zhu Y; Wang Z; Huang Z; Li Y; Wu H
    Clin Genet; 2013 Jan; 83(1):78-82. PubMed ID: 22320238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease and development.
    Walter MA; Goodfellow PN
    Nature; 1992 Feb; 355(6361):590-1. PubMed ID: 1538745
    [No Abstract]   [Full Text] [Related]  

  • 16. Three novel PAX3 mutations observed in patients with Waardenburg syndrome type 1.
    Soejima H; Fujimoto M; Tsukamoto K; Matsumoto N; Yoshiura KI; Fukushima Y; Jinno Y; Niikawa N
    Hum Mutat; 1997; 9(2):177-80. PubMed ID: 9067759
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of Pax3 modifier genes on craniofacial morphology, pigmentation, and viability: a murine model of Waardenburg syndrome variation.
    Asher JH; Harrison RW; Morell R; Carey ML; Friedman TB
    Genomics; 1996 Jun; 34(3):285-98. PubMed ID: 8786127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The mutational spectrum in Waardenburg syndrome.
    Tassabehji M; Newton VE; Liu XZ; Brady A; Donnai D; Krajewska-Walasek M; Murday V; Norman A; Obersztyn E; Reardon W
    Hum Mol Genet; 1995 Nov; 4(11):2131-7. PubMed ID: 8589691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epistatic relationship between Waardenburg syndrome genes MITF and PAX3.
    Watanabe A; Takeda K; Ploplis B; Tachibana M
    Nat Genet; 1998 Mar; 18(3):283-6. PubMed ID: 9500554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in PAX3 associated with Waardenburg syndrome type I.
    Baldwin CT; Lipsky NR; Hoth CF; Cohen T; Mamuya W; Milunsky A
    Hum Mutat; 1994; 3(3):205-11. PubMed ID: 8019556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.